azathioprine has been researched along with Lung Diseases, Interstitial in 81 studies
Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.
Lung Diseases, Interstitial: A diverse group of lung diseases that affect the lung parenchyma. They are characterized by an initial inflammation of PULMONARY ALVEOLI that extends to the interstitium and beyond leading to diffuse PULMONARY FIBROSIS. Interstitial lung diseases are classified by their etiology (known or unknown causes), and radiological-pathological features.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The objective of this study was to evaluate the effect of AZA and MMF on lung function and prednisone dose in myositis-related ILD (M-ILD)." | 7.91 | Long-Term Treatment With Azathioprine and Mycophenolate Mofetil for Myositis-Related Interstitial Lung Disease. ( Albayda, J; Casal-Dominguez, M; Christopher-Stine, L; Danoff, SK; Huapaya, JA; Johnson, C; Mammen, AL; Paik, JJ; Pinal-Fernandez, I; Sanyal, A; Silhan, L, 2019) |
| " We report the successful use of oral cyclophosphamide, followed by azathioprine maintenance, in the treatment of a patient with dermatomyositis-related rapidly deteriorating ILD, resistant to steroid." | 7.72 | Successful treatment of dermatomyositis-related rapidly progressive interstitial pneumonitis with sequential oral cyclophosphamide and azathioprine. ( Mok, CC; Szeto, ML; To, CH, 2003) |
| "The clinical features of ASS include interstitial lung disease (ILD), myositis, arthritis, Raynaud's phenomenon, mechanic's hands, and unexplained fever." | 5.72 | A 25-Year-Old Saudi Woman with a 2-Year History of Antisynthetase Syndrome with Interstitial Lung Disease Who Commenced Azathioprine Treatment in the Third Trimester of Pregnancy and Had a Successful Birth at Term. ( Alshwairikh, LA; Babay, Z, 2022) |
| " The objective of this study was to evaluate the effect of AZA and MMF on lung function and prednisone dose in myositis-related ILD (M-ILD)." | 3.91 | Long-Term Treatment With Azathioprine and Mycophenolate Mofetil for Myositis-Related Interstitial Lung Disease. ( Albayda, J; Casal-Dominguez, M; Christopher-Stine, L; Danoff, SK; Huapaya, JA; Johnson, C; Mammen, AL; Paik, JJ; Pinal-Fernandez, I; Sanyal, A; Silhan, L, 2019) |
| "We identified all patients treated for PM/DM-ILD and assessed cyclophosphamide (CYC), azathioprine (AZA) and mycophenolate (MMF) when used as first-line steroid sparing therapy for effects on pulmonary function variables, dyspnea and tolerance at six and twelve months." | 3.79 | A retrospective review of clinical features and treatment outcomes in steroid-resistant interstitial lung disease from polymyositis/dermatomyositis. ( Arrossi, V; Chapman, JT; Culver, DA; Mira-Avendano, IC; Parambil, JG; Xu, M; Yadav, R, 2013) |
| " In univariate analysis, older age at PM/DM onset, anemia, thrombocytopenia, leukopenia, diabetes mellitus, ILD, cancer, and non-use of azathioprine were associated with higher mortality (p = 0." | 3.77 | Survival analysis of patients with dermatomyositis and polymyositis: analysis of 192 Chinese cases. ( Chang, HC; Chen, IJ; Ho, HH; Kuo, CF; Luo, SF; See, LC; Shen, YM; Wu, YJ; Yu, KH, 2011) |
| " We report the successful use of oral cyclophosphamide, followed by azathioprine maintenance, in the treatment of a patient with dermatomyositis-related rapidly deteriorating ILD, resistant to steroid." | 3.72 | Successful treatment of dermatomyositis-related rapidly progressive interstitial pneumonitis with sequential oral cyclophosphamide and azathioprine. ( Mok, CC; Szeto, ML; To, CH, 2003) |
| " Patients were treated with azathioprine and low-dose prednisone if they had progressive pulmonary symptoms (deterioration in the dyspnea score) or poor or deteriorating lung function." | 3.72 | Experience with azathioprine in systemic sclerosis associated with interstitial lung disease. ( Cassim, B; Dheda, K; Lalloo, UG; Mody, GM, 2004) |
| "A 47-year-old man with dermatomyositis and interstitial pneumonia had been treated with prednisolone since May, 1992, and with azathioprine since April, 1993." | 3.69 | [Primary pulmonary non-Hodgkin's lymphoma in a patient with dermatomyositis]. ( Arima, N; Kawamata, N; Kohyama, T; Mori, H; Tanaka, H; Terashi, K; Yamada, H; Yamaguchi, A, 1997) |
| "Rheumatoid arthritis (RA)-associated interstitial lung disease (ILD) is common in patients with RA and leads to significant morbidity and mortality." | 3.30 | Treatment Outcomes for Rheumatoid Arthritis-Associated Interstitial Lung Disease: A Real-World, Multisite Study of the Impact of Immunosuppression on Pulmonary Function Trajectory. ( Baqir, M; Boente, RD; Dai, J; Demoruelle, MK; Diaz, FJ; Donatelli, JM; Hamblin, MB; Iannazzo, NS; Kent, J; Lee, JS; Marll, M; Mathai, SK; Matson, SM; Moua, T; Pope, K; Ryu, JH; Walker, CM, 2023) |
| " Long-term therapy with infliximab, however, was associated with severe adverse events in two out of three SLE patients, which may have been provoked by infliximab and/or by their long-standing refractory SLE and previous therapies." | 2.74 | Adverse events and efficacy of TNF-alpha blockade with infliximab in patients with systemic lupus erythematosus: long-term follow-up of 13 patients. ( Aringer, M; Gordon, C; Graninger, WB; Houssiau, F; Rath, E; Smolen, JS; Steiner, G; Voll, RE, 2009) |
| "To review advances in the management of idiopathic inflammatory myopathy-associated interstitial lung disease (IIM-associated ILD) in the past 5 years, with highlights in myositis-specific antibody (MSA) groups." | 2.58 | Management of Interstitial Lung Disease in Patients With Myositis Specific Autoantibodies. ( Christopher-Stine, L; Mecoli, CA, 2018) |
| "Interstitial lung disease is commonly associated with the autoimmune inflammatory myopathies dermatomyositis and polymyositis and accounts for significant morbidity and mortality in these conditions." | 2.46 | Interstitial lung disease associated with the idiopathic inflammatory myopathies: what progress has been made in the past 35 years? ( Christopher-Stine, L; Connors, GR; Danoff, SK; Oddis, CV, 2010) |
| "The clinical features of ASS include interstitial lung disease (ILD), myositis, arthritis, Raynaud's phenomenon, mechanic's hands, and unexplained fever." | 1.72 | A 25-Year-Old Saudi Woman with a 2-Year History of Antisynthetase Syndrome with Interstitial Lung Disease Who Commenced Azathioprine Treatment in the Third Trimester of Pregnancy and Had a Successful Birth at Term. ( Alshwairikh, LA; Babay, Z, 2022) |
| "Granulomatous and lymphocytic interstitial lung disease (GLILD) is a life-threatening complication in patients with common variable immunodeficiency (CVID), but the optimal treatment is unknown." | 1.62 | Rituximab and antimetabolite treatment of granulomatous and lymphocytic interstitial lung disease in common variable immunodeficiency. ( Barbeau, J; Baruah, D; Bausch-Jurken, M; Busalacchi, A; Chen, S; Cool, CD; Feng, M; Hammelev, E; Hintermeyer, MK; Rao, N; Routes, JM; Rymaszewski, A; Simpson, PM; Sosa-Lozano, LA; Verbsky, JW; Woodliff, J, 2021) |
| "Extended diagnostic measures revealed interstitial lung disease (ILD), polyserositis, polyarthritis and myopathy." | 1.51 | [Progressive respiratory failure and weakness in a 61-year-old woman]. ( Mahmud, M; Schnoor, U; Steinmetz, OM, 2019) |
| "A muscle biopsy was consistent with inflammatory myopathy." | 1.51 | Antisynthetase syndrome presenting as interstitial lung disease: a case report. ( Badshah, A; Haider, I; Humayun, M; Pervez, S, 2019) |
| "A 66-year-old woman with a history of interstitial lung disease presented with a 3-month history of dropped head syndrome (DHS), followed by camptocormia and extremity weakness." | 1.48 | Dropped Head Syndrome and the Presence of Rimmed Vacuoles in a Muscle Biopsy in Scleroderma-polymyositis Overlap Syndrome Associated with Anti-Ku Antibody. ( Higuchi, I; Jonosono, M; Mitsuyo, K; Yoshida, M; Yoshida, T, 2018) |
| "Interstitial lung disease is one of the most serious pulmonary complications, and the early diagnosis is essential to initiate a prompt therapy." | 1.43 | Pulmonary Langerhans Histiocytosis: an uncommon cause of interstitial pneumonia in a patient with Sjögren syndrome. ( Callejas Rubio, JL; González García, A; Ortego Centeno, N; Ríos Fernández, R, 2016) |
| "Azathioprine is a commonly prescribed therapy for connective tissue disease-associated interstitial lung disease (CTD-ILD)." | 1.43 | Azathioprine response in patients with fibrotic connective tissue disease-associated interstitial lung disease. ( Adegunsoye, A; Chen, L; Chung, JH; Hsu, S; Lee, C; Montner, S; Noth, I; Oldham, JM; Strek, ME; Valenzi, E; Vij, R; Witt, LJ, 2016) |
| "Subgroup of idiopathic inflammatory myopathies, the antisynthetase syndrome is a rare chronic autoimmune disease, which is characterised by the presence of antibodies directed against aminoacyl-t-RNA-synthetases (family of intracytoplasmic enzymes with a vital role in the protein synthesis)." | 1.42 | Interstitial lung disease as first clinical manifestation within the antisynthetase syndrome--dermatomyositis. ( Mlădinescu, OF; Oancea, C; Trăilă, D; Tudorache, V, 2015) |
| "Interstitial lung disease is a rare but recognised complication of rituximab but has been rarely reported in the setting of ITP." | 1.38 | Rituximab-induced interstitial lung disease in a patient with immune thrombocytopenia purpura. ( Berkahn, L; Child, N; O'Carroll, M, 2012) |
| "Acute interstitial pneumonitis is the main pulmonary side effect during MTX treatment." | 1.35 | [Pneumonitis associated to methotrexate]. ( Marquina Barcos, A; Monón Ballarín, S; Mozota Duarte, J; Ruiz-Ruiz, FJ; Sáenz Abad, D, 2008) |
| "Azathioprine therapy was discontinued as a potential source of the pulmonary infiltrate." | 1.34 | A case of interstitial pneumonitis in a patient with ulcerative colitis treated with azathioprine. ( Kiss, I; Lonovics, J; Makula, E; Milassin, P; Molnar, T; Nagy, F; Tiszlavicz, L; Zollei, E, 2007) |
| "The azathioprine therapy was discontinued as the potential source of the pulmonary infiltrate." | 1.33 | [Azathioprine-associated interstitial pneumonitis]. ( Kiss, I; Lonovics, J; Makula, E; Milassin, P; Molnár, T; Nagy, F; Tiszlavicz, L; Zöllei, E, 2006) |
| "Sirolimus is an immunosuppressive drug which has proved its effectivity to reduce the incidence of acute rejection in renal transplantation receptors." | 1.32 | [Interstitial pneumonitis associated with sirolimus administration in a renal transplantation patient: a clinical case]. ( Gentil, MA; González Roncero, FM; López, M; Martínez, M; Mateos, J; Pereira, P; Rodríguez Algarra, G; Toro, J; Valdivia, MA, 2004) |
| "Retreatment with prednisolone and azathioprine has resulted in its improvement." | 1.31 | [Interstitial pneumonia associated with chronic thyroiditis]. ( Hashizume, T; Matsushita, K; Numata, H, 2002) |
| "We report a patient with microscopic polyarteritis nodosa (mPN) and interstitial pneumonia, who was subjected to investigation by bronchoalveolar lavage (BAL), thoracic computerized tomography (CT) and gallium-67 citrate (67Ga) scintigraphy before and after administration of glucocorticoid and immunosuppressive agents." | 1.30 | A case of microscopic polyarteritis nodosa with interstitial pneumonia successfully treated with steroid pulse therapy and immunosuppressive agents. ( Fujishima, M; Fujiwara, M; Hatama, S; Kumagai, H, 1998) |
| "Pulmonary involvement in mixed connective tissue disease has been considered to be relatively benign and easily treated with corticosteroids." | 1.29 | [Interstitial pneumonia associated with mixed connective tissue disease--marked improvement with azathioprine]. ( Aoki, S; Iwase, A; Kitamura, S; Matsuoka, R; Nagayama, T; Sakamoto, K; Shimizu, K; Suzuki, M, 1996) |
| "We conclude that the frequency of interstitial lung disease is high in Sjögren's syndrome and that an azathioprine-based treatment can favorably change the outcome in this population." | 1.29 | Interstitial lung disease in primary Sjögren's syndrome. Clinical-pathological evaluation and response to treatment. ( Barbas Filho, JV; Capelozzi, VL; de Carvalho, CR; Deheinzelin, D; Kairalla, RA; Saldiva, PH, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 13 (16.05) | 18.2507 |
| 2000's | 23 (28.40) | 29.6817 |
| 2010's | 31 (38.27) | 24.3611 |
| 2020's | 14 (17.28) | 2.80 |
| Authors | Studies |
|---|---|
| Wong, AW | 2 |
| Khor, YH | 2 |
| Donohoe, K | 1 |
| Comes, A | 1 |
| Marcoux, V | 1 |
| Fisher, JH | 1 |
| Johannson, KA | 2 |
| Assayag, D | 1 |
| Morisset, J | 1 |
| Shapera, S | 1 |
| Khalil, N | 1 |
| Fell, CD | 1 |
| Manganas, H | 1 |
| Cox, G | 1 |
| To, T | 1 |
| Gershon, AS | 1 |
| Hambly, N | 1 |
| Halayko, AJ | 1 |
| Sadatsafavi, M | 1 |
| Wilcox, PG | 1 |
| Kolb, M | 1 |
| Richeldi, L | 1 |
| Ryerson, CJ | 2 |
| Lok, SD | 1 |
| Alshwairikh, LA | 1 |
| Babay, Z | 1 |
| Matson, SM | 2 |
| Baqir, M | 2 |
| Moua, T | 2 |
| Marll, M | 2 |
| Kent, J | 2 |
| Iannazzo, NS | 2 |
| Boente, RD | 2 |
| Donatelli, JM | 2 |
| Dai, J | 2 |
| Diaz, FJ | 2 |
| Demoruelle, MK | 2 |
| Hamblin, MB | 2 |
| Mathai, SK | 2 |
| Ryu, JH | 2 |
| Pope, K | 2 |
| Walker, CM | 2 |
| Lee, JS | 2 |
| Zhang, D | 1 |
| Adegunsoye, A | 2 |
| Oldham, JM | 2 |
| Kozlitina, J | 1 |
| Garcia, N | 1 |
| Poonawalla, M | 1 |
| Strykowski, R | 1 |
| Linderholm, AL | 1 |
| Ley, B | 1 |
| Ma, SF | 1 |
| Noth, I | 2 |
| Strek, ME | 2 |
| Wolters, PJ | 1 |
| Garcia, CK | 1 |
| Newton, CA | 1 |
| Gao, R | 1 |
| Pu, J | 1 |
| Wang, Y | 1 |
| Wu, Z | 1 |
| Liang, Y | 1 |
| Song, J | 1 |
| Pan, S | 1 |
| Han, F | 1 |
| Yang, L | 1 |
| Xu, X | 1 |
| Tang, J | 1 |
| Wang, X | 1 |
| Ibraheim, MK | 1 |
| Govindu, RR | 1 |
| Verbsky, JW | 2 |
| Hintermeyer, MK | 2 |
| Simpson, PM | 2 |
| Feng, M | 1 |
| Barbeau, J | 1 |
| Rao, N | 1 |
| Cool, CD | 1 |
| Sosa-Lozano, LA | 1 |
| Baruah, D | 1 |
| Hammelev, E | 1 |
| Busalacchi, A | 1 |
| Rymaszewski, A | 1 |
| Woodliff, J | 1 |
| Chen, S | 1 |
| Bausch-Jurken, M | 1 |
| Routes, JM | 2 |
| Tzilas, V | 1 |
| Kahn, N | 1 |
| Bouros, D | 1 |
| Amlani, B | 1 |
| Elsayed, G | 1 |
| Barvalia, U | 1 |
| Kanne, JP | 1 |
| Meyer, KC | 1 |
| Sandbo, N | 1 |
| Li, Z | 1 |
| McCoy, SS | 1 |
| Taha, N | 1 |
| Hosein, K | 1 |
| Grant-Orser, A | 1 |
| Lin-Shaw, A | 1 |
| Mura, M | 1 |
| Rasheed, N | 1 |
| Ahuja, R | 1 |
| Borneo, H | 1 |
| Kiboshi, T | 1 |
| Kotani, T | 2 |
| Konma, J | 1 |
| Makino, H | 1 |
| Matsuda, S | 1 |
| Suzuka, T | 1 |
| Wada, Y | 1 |
| Shiba, H | 1 |
| Hata, K | 1 |
| Shoda, T | 1 |
| Takeuchi, T | 2 |
| Moctezuma, SI | 1 |
| Panizo, CM | 1 |
| Landecho, MF | 1 |
| Yoshida, T | 2 |
| Yoshida, M | 1 |
| Mitsuyo, K | 1 |
| Jonosono, M | 1 |
| Higuchi, I | 1 |
| Gorospe, L | 1 |
| de la Puente-Bujidos, C | 1 |
| García-Gómez-Muriel, I | 1 |
| Barbolla-Díaz, I | 1 |
| Fernández-Méndez, MÁ | 1 |
| Mecoli, CA | 1 |
| Christopher-Stine, L | 3 |
| Mahmud, M | 1 |
| Schnoor, U | 1 |
| Steinmetz, OM | 1 |
| Palawisuth, S | 1 |
| Kantikosum, K | 1 |
| Patiyasikunt, M | 1 |
| Sriprasart, T | 1 |
| Asawanonda, P | 1 |
| Rerknimitr, P | 1 |
| Ron, R | 1 |
| Ruz-Caracuel, I | 1 |
| García, E | 1 |
| Montes-Ramírez, ML | 1 |
| Huapaya, JA | 1 |
| Silhan, L | 1 |
| Pinal-Fernandez, I | 1 |
| Casal-Dominguez, M | 1 |
| Johnson, C | 1 |
| Albayda, J | 1 |
| Paik, JJ | 1 |
| Sanyal, A | 1 |
| Mammen, AL | 1 |
| Danoff, SK | 2 |
| Zheng, JN | 1 |
| Yang, QR | 1 |
| Zhu, GQ | 1 |
| Pan, L | 1 |
| Xia, JX | 1 |
| Wang, Q | 1 |
| Badshah, A | 1 |
| Haider, I | 1 |
| Pervez, S | 1 |
| Humayun, M | 1 |
| Mira-Avendano, IC | 1 |
| Parambil, JG | 1 |
| Yadav, R | 1 |
| Arrossi, V | 1 |
| Xu, M | 1 |
| Chapman, JT | 1 |
| Culver, DA | 1 |
| Bozkirli, DE | 1 |
| Kozanoglu, I | 1 |
| Bozkirli, E | 1 |
| Yucel, E | 1 |
| Poormoghim, H | 1 |
| Rezaei, N | 1 |
| Sheidaie, Z | 1 |
| Almasi, AR | 1 |
| Moradi-Lakeh, M | 1 |
| Almasi, S | 1 |
| Andalib, E | 1 |
| Iudici, M | 1 |
| Cuomo, G | 1 |
| Vettori, S | 1 |
| Bocchino, M | 1 |
| Sanduzzi Zamparelli, A | 1 |
| Cappabianca, S | 1 |
| Valentini, G | 1 |
| González García, A | 1 |
| Callejas Rubio, JL | 1 |
| Ríos Fernández, R | 1 |
| Ortego Centeno, N | 1 |
| Gupta, R | 1 |
| Espiritu, J | 1 |
| Trăilă, D | 1 |
| Mlădinescu, OF | 1 |
| Oancea, C | 1 |
| Tudorache, V | 1 |
| Muñoz Gómez, MM | 1 |
| Montané, E | 1 |
| Arellano, AL | 1 |
| Olivé, A | 1 |
| Pathria, M | 1 |
| Urbine, D | 1 |
| Zumberg, MS | 1 |
| Guarderas, J | 1 |
| Steele, CL | 1 |
| Doré, M | 1 |
| Ammann, S | 1 |
| Loughrey, M | 1 |
| Montero, A | 1 |
| Burns, SO | 1 |
| Morris, EC | 1 |
| Gaspar, B | 1 |
| Gilmour, K | 1 |
| Bibi, S | 1 |
| Shendi, H | 1 |
| Devlin, L | 1 |
| Speckmann, C | 1 |
| Edgar, DM | 1 |
| Lee, C | 1 |
| Valenzi, E | 1 |
| Witt, LJ | 1 |
| Hsu, S | 1 |
| Chen, L | 1 |
| Montner, S | 1 |
| Chung, JH | 1 |
| Vij, R | 1 |
| Polosa, R | 1 |
| Di Mauro, C | 1 |
| Spampinato, B | 1 |
| Castelli, L | 1 |
| D'Amico, G | 1 |
| Edwards, CJ | 1 |
| Russo, C | 1 |
| Taki, H | 1 |
| Kawagishi, Y | 1 |
| Shinoda, K | 1 |
| Hounoki, H | 1 |
| Ogawa, R | 1 |
| Sugiyama, E | 1 |
| Tobe, K | 1 |
| Hernández Pérez, JM | 1 |
| Acosta Fernández, O | 1 |
| Aringer, M | 1 |
| Houssiau, F | 1 |
| Gordon, C | 1 |
| Graninger, WB | 1 |
| Voll, RE | 1 |
| Rath, E | 1 |
| Steiner, G | 1 |
| Smolen, JS | 1 |
| Bussone, G | 1 |
| Mouthon, L | 2 |
| Woischnik, M | 2 |
| Sparr, C | 2 |
| Kern, S | 2 |
| Thurm, T | 2 |
| Hector, A | 2 |
| Hartl, D | 2 |
| Liebisch, G | 2 |
| Mulugeta, S | 1 |
| Beers, MF | 1 |
| Schmitz, G | 2 |
| Griese, M | 2 |
| Connors, GR | 1 |
| Oddis, CV | 1 |
| Suto, M | 1 |
| Nagai, Y | 1 |
| Hasegawa, M | 1 |
| Handa, H | 1 |
| Ishikawa, O | 1 |
| Wuyts, WA | 1 |
| Thomeer, M | 1 |
| Demedts, MG | 1 |
| Patel, HC | 1 |
| Lauder, NN | 1 |
| Yu, KH | 1 |
| Wu, YJ | 1 |
| Kuo, CF | 1 |
| See, LC | 1 |
| Shen, YM | 1 |
| Chang, HC | 1 |
| Luo, SF | 1 |
| Ho, HH | 1 |
| Chen, IJ | 1 |
| Child, N | 1 |
| O'Carroll, M | 1 |
| Berkahn, L | 1 |
| Zarbock, R | 1 |
| Kaltenborn, E | 1 |
| Ishida, T | 1 |
| Makino, S | 1 |
| Chase, NM | 1 |
| Waukau, JK | 1 |
| Tomita-Mitchell, A | 1 |
| Casper, JT | 1 |
| Singh, S | 1 |
| Shahir, KS | 1 |
| Tisol, WB | 1 |
| Nugent, ML | 1 |
| Rao, RN | 1 |
| Mackinnon, AC | 1 |
| Goodman, LR | 1 |
| Mok, CC | 1 |
| To, CH | 1 |
| Szeto, ML | 1 |
| Sharma, S | 1 |
| Field, SK | 1 |
| Martínez, M | 1 |
| González Roncero, FM | 1 |
| López, M | 1 |
| Toro, J | 1 |
| Valdivia, MA | 1 |
| Pereira, P | 1 |
| Gentil, MA | 1 |
| Rodríguez Algarra, G | 1 |
| Mateos, J | 1 |
| Dheda, K | 1 |
| Lalloo, UG | 1 |
| Cassim, B | 1 |
| Mody, GM | 1 |
| Kaşifoğlu, T | 1 |
| Korkmaz, C | 1 |
| Ozkan, R | 1 |
| Nathan, SD | 1 |
| Sugimoto, T | 1 |
| Kanasaki, K | 1 |
| Koyama, T | 1 |
| Yokomaku, Y | 1 |
| Yasuda, H | 1 |
| Kashiwagi, A | 1 |
| Koya, D | 1 |
| Nagy, F | 2 |
| Molnár, T | 2 |
| Makula, E | 2 |
| Kiss, I | 2 |
| Milassin, P | 2 |
| Zöllei, E | 2 |
| Tiszlavicz, L | 2 |
| Lonovics, J | 2 |
| Cottin, V | 1 |
| Muñoz, A | 1 |
| Aranda, I | 1 |
| Pascual, J | 1 |
| Ferrando, C | 1 |
| Bakker, JA | 1 |
| Bierau, J | 1 |
| Drent, M | 1 |
| Sáenz Abad, D | 1 |
| Ruiz-Ruiz, FJ | 1 |
| Monón Ballarín, S | 1 |
| Mozota Duarte, J | 1 |
| Marquina Barcos, A | 1 |
| Bérezné, A | 1 |
| Ranque, B | 1 |
| Valeyre, D | 1 |
| Brauner, M | 1 |
| Allanore, Y | 1 |
| Launay, D | 1 |
| Le Guern, V | 1 |
| Kahn, JE | 1 |
| Couderc, LJ | 1 |
| Constans, J | 1 |
| Cohen, P | 1 |
| Mahr, A | 1 |
| Pagnoux, C | 1 |
| Hachulla, E | 1 |
| Kahan, A | 1 |
| Cabane, J | 1 |
| Guillevin, L | 1 |
| Pillans, PI | 1 |
| Tooke, AF | 1 |
| Bateman, ED | 1 |
| Ainslie, GM | 1 |
| Hizawa, N | 1 |
| Kojima, J | 1 |
| Kojima, T | 1 |
| Sukoh, N | 1 |
| Yamaguchi, E | 1 |
| Kawakami, Y | 1 |
| Matsushima, T | 1 |
| McCune, WJ | 1 |
| Vallance, DK | 1 |
| Lynch, JP | 1 |
| Suzuki, M | 1 |
| Shimizu, K | 1 |
| Sakamoto, K | 1 |
| Iwase, A | 1 |
| Aoki, S | 1 |
| Matsuoka, R | 1 |
| Nagayama, T | 1 |
| Kitamura, S | 1 |
| Deheinzelin, D | 1 |
| Capelozzi, VL | 1 |
| Kairalla, RA | 1 |
| Barbas Filho, JV | 1 |
| Saldiva, PH | 1 |
| de Carvalho, CR | 1 |
| Sacco, O | 1 |
| Fregonese, B | 1 |
| Picco, P | 1 |
| Faraci, M | 1 |
| Facchetti, P | 1 |
| Pistoia, V | 1 |
| Rossi, GA | 1 |
| Hirata, Y | 1 |
| Takizawa, H | 1 |
| Okazaki, H | 1 |
| Yoshida, A | 1 |
| Ishii, A | 1 |
| Kohno, T | 1 |
| Nakajima, J | 1 |
| Oka, T | 1 |
| Ito, K | 1 |
| Mori, H | 1 |
| Yamada, H | 1 |
| Terashi, K | 1 |
| Kohyama, T | 1 |
| Kawamata, N | 1 |
| Yamaguchi, A | 1 |
| Arima, N | 1 |
| Tanaka, H | 1 |
| Sauty, A | 1 |
| Rochat, T | 1 |
| Schoch, OD | 1 |
| Hamacher, J | 1 |
| Kurt, AM | 1 |
| Dayer, JM | 1 |
| Nicod, LP | 1 |
| Strobel, ES | 1 |
| Bonnet, RB | 1 |
| Werner, P | 1 |
| Schaefer, HE | 1 |
| Peter, HH | 1 |
| Hatama, S | 1 |
| Kumagai, H | 1 |
| Fujiwara, M | 1 |
| Fujishima, M | 1 |
| Cheema, GS | 1 |
| Quismorio, FP | 1 |
| Koga, H | 1 |
| Saitoh, F | 1 |
| Sakamoto, M | 1 |
| Harada, M | 1 |
| Yoshida, H | 1 |
| Sakisaka, S | 1 |
| Sata, M | 1 |
| Perreaux, F | 1 |
| Zenaty, D | 1 |
| Capron, F | 1 |
| Trioche, P | 1 |
| Odièvre, M | 1 |
| Labrune, P | 1 |
| Mimura, T | 1 |
| Kanda, H | 1 |
| Kubo, K | 1 |
| Hellmich, B | 1 |
| Schnabel, A | 1 |
| Bauer, T | 1 |
| Schatz, H | 1 |
| Hashizume, T | 1 |
| Numata, H | 1 |
| Matsushita, K | 1 |
11 reviews available for azathioprine and Lung Diseases, Interstitial
| Article | Year |
|---|---|
Management of Interstitial Lung Disease in Patients With Myositis Specific Autoantibodies.
Topics: Autoantibodies; Autoimmune Diseases; Azathioprine; Calcineurin Inhibitors; Humans; Immunosuppressive | 2018 |
Management of granulomatous lymphocytic interstitial lung disease in a patient with common variable immune deficiency.
Topics: Azathioprine; Common Variable Immunodeficiency; Cough; Dyspnea; Female; Humans; Immunoglobulins, Int | 2016 |
Interstitial lung disease in systemic sclerosis.
Topics: Antibodies, Monoclonal, Murine-Derived; Autoantibodies; Azathioprine; Contraindications; Cyclophosph | 2011 |
Interstitial lung disease associated with the idiopathic inflammatory myopathies: what progress has been made in the past 35 years?
Topics: Adrenal Cortex Hormones; Antineoplastic Combined Chemotherapy Protocols; Azathioprine; Biomarkers; B | 2010 |
Newer modes of treating interstitial lung disease.
Topics: Acetylcysteine; Adrenal Cortex Hormones; Azathioprine; Humans; Lung Diseases, Interstitial; Lung Tra | 2011 |
Therapeutic intervention: assessing the role of the international consensus guidelines.
Topics: Animals; Azathioprine; Cyclophosphamide; Drug Therapy, Combination; Glucocorticoids; Humans; Immunos | 2005 |
[Idiopathic interstitial pneumonia: treatment].
Topics: Acetylcysteine; Acute Disease; Adrenal Cortex Hormones; Adult; Age Factors; Aged; Azathioprine; Benz | 2006 |
Acute polyarthritis associated with azathioprine for interstitial lung disease.
Topics: Acute Disease; Arthritis; Azathioprine; Drug Hypersensitivity; Drug Therapy, Combination; Female; Hu | 1995 |
Immunosuppressive drug therapy.
Topics: Adrenal Cortex Hormones; Azathioprine; Chlorambucil; Clinical Trials as Topic; Cyclophosphamide; Cyc | 1994 |
Pulmonary involvement in adult-onset Still's disease.
Topics: Adrenal Cortex Hormones; Adult; Azathioprine; Chronic Disease; Cyclophosphamide; Humans; Immunoglobu | 1999 |
[Treatment of steroid-resistant polymyositis and dermatomyositis].
Topics: Animals; Anti-Inflammatory Agents; Azathioprine; Cyclophosphamide; Cyclosporine; Dermatomyositis; Dr | 2001 |
4 trials available for azathioprine and Lung Diseases, Interstitial
66 other studies available for azathioprine and Lung Diseases, Interstitial
| Article | Year |
|---|---|
Prescribing Patterns and Tolerability of Mycophenolate and Azathioprine in Patients with Nonidiopathic Pulmonary Fibrosis Fibrotic Interstitial Lung Disease.
Topics: Azathioprine; Fibrosis; Humans; Idiopathic Pulmonary Fibrosis; Immunosuppressive Agents; Lung Diseas | 2022 |
Malignancy Risk Associated With Mycophenolate Mofetil or Azathioprine in Patients With Fibrotic Interstitial Lung Disease.
Topics: Azathioprine; Humans; Immunosuppressive Agents; Lung Diseases, Interstitial; Mycophenolic Acid; Neop | 2022 |
A 25-Year-Old Saudi Woman with a 2-Year History of Antisynthetase Syndrome with Interstitial Lung Disease Who Commenced Azathioprine Treatment in the Third Trimester of Pregnancy and Had a Successful Birth at Term.
Topics: Adult; Autoantibodies; Autoimmune Diseases; Azathioprine; Female; Humans; Lung Diseases, Interstitia | 2022 |
Telomere length and immunosuppression in non-idiopathic pulmonary fibrosis interstitial lung disease.
Topics: Azathioprine; Connective Tissue Diseases; Humans; Idiopathic Pulmonary Fibrosis; Immunosuppression T | 2023 |
Rheumatoid Arthritis-Associated Interstitial Lung Disease.
Topics: Arthritis, Rheumatoid; Azathioprine; Dyspnea; Hand; Humans; Lung; Lung Diseases, Interstitial; Male; | 2020 |
Rituximab and antimetabolite treatment of granulomatous and lymphocytic interstitial lung disease in common variable immunodeficiency.
Topics: Adolescent; Adult; Azathioprine; Common Variable Immunodeficiency; Enzyme Inhibitors; Female; Humans | 2021 |
Azathioprine for Connective Tissue Disease-Associated Interstitial Lung Disease: In Search for Evidence-Based Medicine.
Topics: Azathioprine; Connective Tissue Diseases; Evidence-Based Medicine; Humans; Lung Diseases, Interstiti | 2020 |
Treatment of primary sjögren's syndrome-related interstitial lung disease: a retrospective cohort study.
Topics: Aged; Aged, 80 and over; Azathioprine; Electronic Health Records; Female; Humans; Immunosuppressive | 2020 |
TPMT and HLA-DQA1-HLA-DRB genetic profiling to guide the use of azathioprine in the treatment of interstitial lung disease: First experience.
Topics: Azathioprine; HLA-DQ alpha-Chains; Humans; Lung Diseases, Interstitial; Methyltransferases | 2021 |
Polyangiitis overlap syndrome: a novel presentation of microscopic polyangiitis and eosinophilic granulomatosis with polyangiitis.
Topics: Antibodies, Antineutrophil Cytoplasmic; Azathioprine; Churg-Strauss Syndrome; Cyclophosphamide; Fema | 2021 |
Comparison of therapeutic effects of combination therapy with prednisolone and tacrolimus or azathioprine on progressive interstitial pneumonia with systemic sclerosis.
Topics: Azathioprine; Drug Therapy, Combination; Fibrosis; Humans; Immunosuppressive Agents; Lung Diseases, | 2022 |
Common variable immunodeficiency-associated granulomatous and lymphocytic interstitial lung disease successfully treated with a combination regimen of rituximab and azathioprine.
Topics: Azathioprine; Common Variable Immunodeficiency; Drug Therapy, Combination; Female; Humans; Immunosup | 2017 |
Dropped Head Syndrome and the Presence of Rimmed Vacuoles in a Muscle Biopsy in Scleroderma-polymyositis Overlap Syndrome Associated with Anti-Ku Antibody.
Topics: Aged; Anti-Inflammatory Agents; Autoantibodies; Azathioprine; Female; Head Movements; Humans; Immuno | 2018 |
Asymmetric Calcinosis in an Adult Patient With Antisynthetase Syndrome.
Topics: Amino Acyl-tRNA Synthetases; Autoantibodies; Azathioprine; Calcinosis; Female; Humans; Immunosuppres | 2019 |
[Progressive respiratory failure and weakness in a 61-year-old woman].
Topics: Amino Acyl-tRNA Synthetases; Antibodies, Antinuclear; Autoantibodies; Azathioprine; Combined Modalit | 2019 |
A Bad Sign: Dermatomyositis with Interstitial Lung Disease.
Topics: Anti-Inflammatory Agents; Azathioprine; Dermatomyositis; Dexamethasone; Fatal Outcome; Humans; Immun | 2019 |
IgG4-related disease in a patient with HIV infection.
Topics: Azathioprine; Dyspnea; Glucocorticoids; HIV Infections; Humans; Immunoglobulin G; Immunoglobulin G4- | 2019 |
Long-Term Treatment With Azathioprine and Mycophenolate Mofetil for Myositis-Related Interstitial Lung Disease.
Topics: Azathioprine; Enzyme Inhibitors; Female; Follow-Up Studies; Forced Expiratory Volume; Glucocorticoid | 2019 |
Comparative efficacy and safety of immunosuppressive therapies for systemic sclerosis related interstitial lung disease: A Bayesian network analysis.
Topics: Adult; Azathioprine; Bayes Theorem; Cyclophosphamide; Female; Humans; Immunosuppressive Agents; Lung | 2020 |
Antisynthetase syndrome presenting as interstitial lung disease: a case report.
Topics: Adult; Antibodies, Antinuclear; Autoantibodies; Azathioprine; Creatine Kinase; Diagnosis, Differenti | 2019 |
A retrospective review of clinical features and treatment outcomes in steroid-resistant interstitial lung disease from polymyositis/dermatomyositis.
Topics: Adult; Azathioprine; Cyclophosphamide; Dermatomyositis; Drug Administration Schedule; Drug Resistanc | 2013 |
Antisynthetase syndrome with refractory lung involvement and myositis successfully treated with double filtration plasmapheresis.
Topics: Aged; Autoantibodies; Azathioprine; Combined Modality Therapy; Creatine Kinase; Cyclophosphamide; Em | 2013 |
Systemic sclerosis: comparison of efficacy of oral cyclophosphamide and azathioprine on skin score and pulmonary involvement-a retrospective study.
Topics: Administration, Oral; Adult; Aged; Azathioprine; Cyclophosphamide; Drug Therapy, Combination; Female | 2014 |
Low-dose pulse cyclophosphamide in interstitial lung disease associated with systemic sclerosis (SSc-ILD): efficacy of maintenance immunosuppression in responders and non-responders.
Topics: Adult; Azathioprine; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Therapy, Combination; | 2015 |
Pulmonary Langerhans Histiocytosis: an uncommon cause of interstitial pneumonia in a patient with Sjögren syndrome.
Topics: 11-beta-Hydroxysteroid Dehydrogenases; Azathioprine; Female; Histiocytosis, Langerhans-Cell; Humans; | 2016 |
Azathioprine for the Rare Case of Nonspecific Interstitial Pneumonitis in a Patient with Psoriasis.
Topics: Adult; Azathioprine; Biopsy; Bronchoscopy; Female; Humans; Immunosuppressive Agents; Lung Diseases, | 2015 |
Interstitial lung disease as first clinical manifestation within the antisynthetase syndrome--dermatomyositis.
Topics: Adult; Antibodies, Antinuclear; Autoantibodies; Azathioprine; Biomarkers; Dermatomyositis; Disease P | 2015 |
[Tacrolimus-induced gynecomastia in a patient with polymyositis].
Topics: Azathioprine; Drug Substitution; Drug Therapy, Combination; Gynecomastia; Humans; Immunosuppressive | 2016 |
X-linked Inhibitor of Apoptosis Complicated by Granulomatous Lymphocytic Interstitial Lung Disease (GLILD) and Granulomatous Hepatitis.
Topics: Azathioprine; Biomarkers; Biopsy; Bone Marrow; Child, Preschool; Female; Genetic Diseases, X-Linked; | 2016 |
Azathioprine response in patients with fibrotic connective tissue disease-associated interstitial lung disease.
Topics: Adult; Aged; Azathioprine; Connective Tissue Diseases; Cross-Over Studies; Female; Hospitalization; | 2016 |
A patient with antihistidyl-tRNA synthetase positive polymyositis presenting as acute respiratory distress syndrome.
Topics: Antirheumatic Agents; Autoantibodies; Azathioprine; Female; Histidine-tRNA Ligase; Humans; Lung Dise | 2008 |
Interstitial pneumonitis associated with infliximab therapy without methotrexate treatment.
Topics: Aged; Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Rheumatoid; Azathioprine; Drug Therap | 2009 |
[Lung disease secondary to morphea en coup de sabre, a form of localized scleroderma].
Topics: Adrenal Cortex Hormones; Adult; Autoantibodies; Azathioprine; Drug Therapy, Combination; Facial Hemi | 2009 |
A non-BRICHOS surfactant protein c mutation disrupts epithelial cell function and intercellular signaling.
Topics: Amino Acid Substitution; Animals; Azathioprine; Bronchoalveolar Lavage Fluid; Calnexin; Calreticulin | 2010 |
Azathioprine-induced pure red cell aplasia in a systemic sclerosis patient with interstitial pneumonia.
Topics: Adult; Azathioprine; Female; Humans; Immunosuppressive Agents; Lung Diseases, Interstitial; Red-Cell | 2011 |
The antisynthetase syndrome.
Topics: Adult; Anti-Inflammatory Agents; Antibodies, Antinuclear; Azathioprine; Cryptogenic Organizing Pneum | 2011 |
Survival analysis of patients with dermatomyositis and polymyositis: analysis of 192 Chinese cases.
Topics: Adult; Aged; Antirheumatic Agents; Azathioprine; Dermatomyositis; Diabetes Complications; Female; Fo | 2011 |
Rituximab-induced interstitial lung disease in a patient with immune thrombocytopenia purpura.
Topics: Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Azathioprine; Combined Modality Therapy; | 2012 |
The surfactant protein C mutation A116D alters cellular processing, stress tolerance, surfactant lipid composition, and immune cell activation.
Topics: Animals; Azathioprine; Cell Line; Cyclophosphamide; Epithelial Cells; Gene Expression; Humans; Hydro | 2012 |
Pulmonary toxicity after initiation of azathioprine for treatment of interstitial pneumonia in a patient with rheumatoid arthritis.
Topics: Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Azathioprine; Dyspnea; Humans; Lung Diseases, Int | 2012 |
Successful treatment of dermatomyositis-related rapidly progressive interstitial pneumonitis with sequential oral cyclophosphamide and azathioprine.
Topics: Administration, Oral; Antirheumatic Agents; Azathioprine; Cyclophosphamide; Dermatomyositis; Disease | 2003 |
Steroids and/or cytotoxic agents should be used early in the management of patients with IPF--the pro argument.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents; Antimetabolites, Antineoplastic; Antineoplastic A | 2004 |
Steroids and/or cytotoxic agents should be used early in the management of patients with IPF - the con argument.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents; Antimetabolites, Antineoplastic; Antineoplastic A | 2004 |
[Interstitial pneumonitis associated with sirolimus administration in a renal transplantation patient: a clinical case].
Topics: Aged; Antilymphocyte Serum; Azathioprine; Cyclosporine; Diagnosis, Differential; Diuretics; Doxazosi | 2004 |
Experience with azathioprine in systemic sclerosis associated with interstitial lung disease.
Topics: Azathioprine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Dyspnea; Female; Glucocor | 2004 |
Cytomegalovirus-induced interstitial pneumonitis in a patient with dermatomyositis.
Topics: Adult; Antiviral Agents; Azathioprine; Cyclosporine; Cytomegalovirus; Cytomegalovirus Infections; De | 2006 |
A case of myeloperoxidase-antineutrophil cytoplasmic antibody positive-polyarteritis nodosa complicated by interstitial pneumonia and rapidly progressive renal failure.
Topics: Aged; Angiography; Anti-Inflammatory Agents; Antibodies, Antineutrophil Cytoplasmic; Azathioprine; F | 2007 |
[Azathioprine-associated interstitial pneumonitis].
Topics: Adult; Azathioprine; Colitis, Ulcerative; Humans; Immunosuppressive Agents; Lung Diseases, Interstit | 2006 |
A case of interstitial pneumonitis in a patient with ulcerative colitis treated with azathioprine.
Topics: Adult; Azathioprine; Colitis, Ulcerative; Humans; Immunosuppressive Agents; Lung Diseases, Interstit | 2007 |
[Idiopathic bronchiolocentric interstitial pneumonia: a new idiopathic interstitial pneumonia].
Topics: Adult; Azathioprine; Biopsy; Diagnosis, Differential; Female; Humans; Immunosuppressive Agents; Lung | 2007 |
Therapeutic regimens in interstitial lung disease guided by genetic screening: fact or fiction?
Topics: Azathioprine; Genetic Testing; Humans; Immunosuppressive Agents; Lung Diseases, Interstitial; Methyl | 2007 |
[Pneumonitis associated to methotrexate].
Topics: Adrenal Cortex Hormones; Azathioprine; Diagnosis, Differential; Female; Humans; Immunosuppressive Ag | 2008 |
Therapeutic strategy combining intravenous cyclophosphamide followed by oral azathioprine to treat worsening interstitial lung disease associated with systemic sclerosis: a retrospective multicenter open-label study.
Topics: Administration, Oral; Adult; Antirheumatic Agents; Azathioprine; Cyclophosphamide; Drug Therapy, Com | 2008 |
A patient with chronic hepatitis C who simultaneously developed interstitial pneumonia, hemolytic anemia and cholestatic liver dysfunction after alpha-interferon administration.
Topics: Anemia, Hemolytic, Autoimmune; Azathioprine; Cholestasis, Intrahepatic; Female; Hepatitis C; Humans; | 1994 |
[Interstitial pneumonia associated with mixed connective tissue disease--marked improvement with azathioprine].
Topics: Azathioprine; Drug Administration Schedule; Humans; Immunosuppressive Agents; Lung Diseases, Interst | 1996 |
Interstitial lung disease in primary Sjögren's syndrome. Clinical-pathological evaluation and response to treatment.
Topics: Adult; Aged; Azathioprine; Bronchoalveolar Lavage Fluid; Female; Humans; Lung Diseases, Interstitial | 1996 |
Common variable immunodeficiency presenting in a girl as lung infiltrates and mediastinal adenopathies leading to severe "superior vena caval" syndrome.
Topics: Anti-Inflammatory Agents; Azathioprine; Child; Common Variable Immunodeficiency; Diagnosis, Differen | 1996 |
[Interstitial pneumonia with Sjögren's syndrome: successful treatment with steroids and an immunosuppressant].
Topics: Adult; Anti-Inflammatory Agents; Azathioprine; Drug Therapy, Combination; Dyspnea; Female; Humans; I | 1997 |
[Primary pulmonary non-Hodgkin's lymphoma in a patient with dermatomyositis].
Topics: Azathioprine; Dermatomyositis; Humans; Immunosuppressive Agents; Lung Diseases, Interstitial; Lung N | 1997 |
Pulmonary fibrosis with predominant CD8 lymphocytic alveolitis and anti-Jo-1 antibodies.
Topics: Aged; Antibodies, Antinuclear; Autoantibodies; Azathioprine; Biopsy, Needle; Bronchoalveolar Lavage | 1997 |
Bronchiolitis obliterans organising pneumonia and primary biliary cirrhosis-like lung involvement in a patient with primary biliary cirrhosis.
Topics: Adrenal Cortex Hormones; Antimetabolites; Azathioprine; Biopsy, Needle; Bronchoalveolar Lavage; Cryp | 1998 |
A case of microscopic polyarteritis nodosa with interstitial pneumonia successfully treated with steroid pulse therapy and immunosuppressive agents.
Topics: Anti-Inflammatory Agents; Azathioprine; Bronchoalveolar Lavage; Cyclophosphamide; Drug Administratio | 1998 |
Pulse intravenous cyclophosphamide treatment for steroid-resistant interstitial pneumonitis associated with polymyositis.
Topics: Adult; Azathioprine; Biopsy; Cyclophosphamide; Drug Therapy, Combination; Female; Humans; Immunosupp | 1999 |
Azathioprine-induced lung toxicity and efficacy of cyclosporin A in a young girl with type 2 autoimmune hepatitis.
Topics: Adolescent; Autoantibodies; Azathioprine; Cyclosporine; Female; Hepatitis, Autoimmune; Humans; Immun | 2000 |
[Interstitial pulmonary disease in systemic scleroderma: treatment].
Topics: Azathioprine; Cytokines; Glucocorticoids; Hematopoietic Stem Cell Transplantation; Humans; Immunosup | 2002 |
[Interstitial pneumonia associated with chronic thyroiditis].
Topics: Anti-Inflammatory Agents; Azathioprine; Chronic Disease; Drug Therapy, Combination; Female; Humans; | 2002 |